Abstract
In France, cancer is the leading cause of death. Its incidence is increasing due to the growing population and longer life expectancy. Although older adults represent most new cases, they remain underrepresented in clinical trials. Their prognosis is often worse due to delayed diagnosis and multimorbidities. Geriatric oncology has made great strides worldwide, highlighted by important studies implementing geriatric assessment in clinical research and supported by the successive national cancer plans. This paper reviews the most important actions taken in France during the last decade to improve the management of older patients with cancer.
Highlights
As in the rest of the Western world, cancer incidence in France is increasing due to the growing population (+20% in 18 years) and the longer life expectancy [1] (Figure 1)
The development of GO in France relies on the joint efforts of two professional communities, oncology and geriatrics, supported politically and financially by public authorities, including the Institut National du Cancer (INCa)
Labelled by INCa in 2014, the DIALOG intergroup has become the main actor to lay out the groundwork and foundations of such collaboration between oncology and geriatrics, in order to strongly promote specific actions in clinical research for older cancer patients at national and international levels, in response to Actions 2.16 and 5.2 of Plan Cancer 2014–2019
Summary
As in the rest of the Western world, cancer incidence in France is increasing due to the growing population (+20% in 18 years) and the longer life expectancy [1] (Figure 1). The development of GO in France relies on the joint efforts of two professional communities, oncology and geriatrics, supported politically and financially by public authorities, including the Institut National du Cancer (INCa).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
